sumatriptan has been researched along with thromboxane a2 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choppin, A; O'Connor, SE | 1 |
| Angus, JA; Cocks, TM; Kemp, BK; Pruneau, D | 1 |
| Cocks, TM; Kemp, BK | 1 |
| Baird, M; Clayton, RA; Johnston, ED; MacLean, MR; Sheridan, S; Sweeney, G; Templeton, A | 1 |
| Bax, WA; Bos, E; Ferrari, MD; Maassen VanDenBrink, A; Saxena, PR; Zijlstra, FJ | 1 |
| Amrani, M; Chester, AH; Sproson, CA; Yacoub, MH | 1 |
6 other study(ies) available for sumatriptan and thromboxane a2
| Article | Year |
|---|---|
Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Rabbits; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Coronary Vessels; Drug Synergism; Ergonovine; Humans; In Vitro Techniques; Isometric Contraction; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1993 |
Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Vessels; Dogs; Drug Interactions; Endothelium, Vascular; Female; In Vitro Techniques; Male; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides, Synthetic; Receptors, Serotonin; Saphenous Vein; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: relationship to tone and cyclic nucleotide levels.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cattle; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Arteries; Child; Child, Preschool; Coronary Vessels; Female; Humans; In Vitro Techniques; Infant; Male; Middle Aged; Potassium; Prostaglandin Endoperoxides, Synthetic; Substance P; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1996 |
Interaction between thromboxane A2 and 5-hydroxytryptamine in the radial artery compared to the internal thoracic artery.
Topics: Aged; Humans; In Vitro Techniques; Mammary Arteries; Middle Aged; Radial Artery; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin; Sumatriptan; Thromboxane A2; Vasoconstriction | 2000 |